THE HAGUE, Netherlands — Bio Innovations Europe, the premier event dedicated to scaling industrial biomanufacturing in the region, is proud to announce EuropaBio as a Headline Partner for its 2026 edition. This strategic partnership bridges the gap between commercial scale-up and the critical policy landscape during a pivotal year for the European bioeconomy.
Taking place on 10-11 June 2026 in The Hague, the event—formerly known as World Bio Markets—has seen exponential growth. Since its 2022 relaunch, pre-arranged meetings have surged from 160 to over 1,050 in 2025—a 550% increase. The 2026 edition is set to be the largest yet, hosting more than 500 attendees and facilitating 1,500 commercial meetings between bio-developers & producers, chemical manufacturers, consumer brands & intermediates, community enablers, investors & financiers and suppliers.
The partnership with EuropaBio, the European Association for Bioindustries, comes at a vital time. With major EU policy initiatives, including the EU Biotech Act, set to catalyse the sector, the collaboration ensures that attendees are at the intersection of business innovation and regulatory evolution.
Paul MacDonald, Co-Founder & MD of Bio Innovations Europe, commented: “I have long been an admirer of the work that Claire and the team at EuropaBio undertake, and I am now proud to call them one of our headline partners. There is no better organisation to bring the policy angle to our event. EuropaBio’s insights and influence will perfectly frame and compliment the commercial connections and dialogue that we are renowned for. We are on a mission to make bio the new normal and I am delighted that EuropaBio are on that journey with us.”
Claire Skentelbery, Director General at EuropaBio, added: “Bio Innovations Europe is a perfect partner for EuropaBio to showcase Europe’s drive towards a thriving and competitive bioeconomy. EuropaBio is leading on the EU Biotech Act plus many other policies that are building an EU single market for biotechnology products in critical sectors including food, feed, chemicals, cosmetics and many more. We look forward to working across the interface of policy and business in this critical conference”
Bio Innovations Europe remains the only event specifically focused on the challenges of moving from lab to market. Alongside Headline Partners EuropaBio and the nova-Institute, the event provides a unique platform for companies creating bio-based chemicals, ingredients, and materials to secure the partnerships and capital required to increase production volumes.
As 2026 marks a turning point for industrial biomanufacturing, Bio Innovations Europe stands as the definitive hub for those driving Europe’s green industrial transition.
For more information, registration, and partnership opportunities, please visit www.bioinnovationseurope.com
–
About Bio Innovations Europe:
Bio Innovations Europe is the leading event for scaling industrial biomanufacturing. By connecting producers with brands, investors, chemical companies, enablers and policy leaders, it facilitates the commercial partnerships necessary to bring bio-based solutions to the global market.
About EuropaBio:
EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. It represents members across the sectors of health, agriculture, and industrial biotechnology, advocating for policies that support a competitive and sustainable bioeconomy.
Media Contact:
Kevin Ward
Head of Marketing
The post EuropaBio joins Bio Innovations Europe 2026 as Headline Partner appeared first on World Bio Market Insights.
- Source: https://worldbiomarketinsights.com/europabio-joins-bio-innovations-europe-2026-as-headline-partner/
